Cargando…
Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance
Asparaginase (ASNase) is a widely applied chemotherapeutic drug that is used to treat Acute Lymphoblastic Leukemia (ALL); however, immune responses and silent inactivation of the drug often limit its bioavailability. Many strategies have been proposed to overcome these drawbacks, including the devel...
Autores principales: | Villanueva-Flores, Francisca, Zárate-Romero, Andrés, Torres, Alfredo G., Huerta-Saquero, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625962/ https://www.ncbi.nlm.nih.gov/pubmed/34834379 http://dx.doi.org/10.3390/pharmaceutics13111965 |
Ejemplares similares
-
A Novel Formulation of Asparaginase Encapsulated into Virus-like Particles of Brome Mosaic Virus: In Vitro and In Vivo Evidence
por: Villanueva-Flores, Francisca, et al.
Publicado: (2023) -
Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment
por: Díaz-Barriga, Cristina, et al.
Publicado: (2021) -
Identification of L-asparaginases from Streptomyces strains with competitive activity and immunogenic profiles: a bioinformatic approach
por: González-Torres, Iván, et al.
Publicado: (2020) -
Rhizobium etli asparaginase II: An alternative for acute lymphoblastic leukemia (ALL) treatment
por: Huerta-Saquero, Alejandro, et al.
Publicado: (2013) -
Peg-Grafted Liposomes for L-Asparaginase Encapsulation
por: de Souza Guimarães, Marina, et al.
Publicado: (2022)